5-09-2025, 01:24

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

Notified -
Globe Newswire5-09-2025, 01:24